Hormonal management of abnormal uterine bleeding.
Singh
Rameet H
RH
Department of Obstetrics and Gynecology, Johns Hopkins Bayview Medical Center, Baltimore, Maryland 21224, USA. rsingh6@jhmi.edu
Blumenthal
Paul
P
D003271:Contraceptive Agents, Female / Q000627:therapeutic use; D003613:Danazol / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D016912:Levonorgestrel / Q000627:therapeutic use; D011374:Progesterone / Q000627:therapeutic use; D045167:Progesterone Congeners / Q000627:therapeutic use; D014592:Uterine Hemorrhage / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
D003271:Contraceptive Agents, Female; D004965:Estrogen Antagonists; D004967:Estrogens; D045167:Progesterone Congeners; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D016912:Levonorgestrel; D003613:Danazol